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Background: The outcome of the autograft therapy for Parkinson’s disease in-
cluding autologous cells from adrenal medulla was disappointing. This could be 
attributed to the pathological process in Parkinson’s disease affecting cells of the 
adrenal medulla. This study was performed to investigate the histopathological 
changes in the adrenal medulla of AS/AGU rat, a model of Parkinson’s disease, 
in comparison with Albino Swiss (AS) rats. 
Materials and methods: A total of 24 male AS rats were divided into four groups, 
each of 6 animals: AS W1 — AS rats aged 1 week; AS adult — AS adult rats; AS/ 
/AGU W1 — AS/AGU rats aged 1 week; and AS/AGU adult — AS/AGU adult rats. 
The rats were sacrificed and the adrenal glands were dissected and processed 
for histological staining with haematoxylin and eosin and periodic acid Schiff 
and for immunohistochemical staining for S100 protein, ubiquitin and tyrosine 
hydroxylase.
Results: The histological investigation of the adrenal medulla of AS/AGU rats 
showed vascular congestion, inflammatory cellular infiltration, pyknotic nuclei, 
necrotic chromaffin cells and medullary inclusion bodies. The immunohistochemical 
investigation of AS/AGU rats showed a statistically significant decrease in the ex-
pression of S100 protein, ubiquitin and tyrosine hydroxylase compared to AS rats.
Conclusions: The histological and immunohistological changes in the adrenal 
medulla could explain the failure of outcome of adrenal autograft therapy in 
Parkinson’s disease. (Folia Morphol 2017; 76, 1: 28–37)
Key words: AS rats, AS/AGU rats, Parkinson’s disease, adrenal medulla, 
histology, immunohistochemistry, S100, ubiquitin, tyrosin hydroxylase
IntrodUctIon
Parkinson’s disease (PD) is a chronic, progressive 
neurodegenerative disorder of unknown aetiology 
that affects 1% of the population over 55 years of 
age. PD is characterised by impairment of movement 
including resting tremors, bradykinesia (slowing of 
voluntary movements), altered gait, muscular rigid-
ity, postural instability, and flat (unemotional, fixed) 
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facial expression. It results from loss of dopamine-
producing neurons in the substantia nigra pars com-
pacta and the presence of intracytoplasmic inclusions 
known as Lewy’s bodies that are formed primarily 
from alpha-synuclein and ubiquitin [2]. These patho-
logical changes occur in the central and peripheral 
nervous system and adrenal medulla [2].
The AS/AGU rat has a spontaneously recessively 
point mutated (agu) gene coding for the gamma iso-
form of protein kinase C (PKC-g) resulting in a failure 
to release dopamine in the striatum of Albino Swiss 
(AS) rat [12, 16]. The AS/AGU rat is characterised 
by serious movement impairments such as rigidity, 
staggering gait, tendency for the hind quarters to 
slip over every few steps, slight whole body tremor, 
and difficulty in initiating movement [9, 12, 36]. 
The movement impairment is resulting from reduced 
tyrosine hydroxylase levels, which reflects the degen-
eration of dopaminergic cells, in substantia nigra pars 
compacta, subthalamic nucleus, and ventrolateral 
thalamus [37]. These manifestations make the AS/ 
/AGU rat a unique model for investigations of the 
integrity of dopaminergic systems in PD [37].
Oral administration of dopamine or its agonists 
is the main treatment of patients complaining of PD 
symptoms. Continuous administration of dopamine 
results in several undesirable side effects including 
drug-induced dyskinesias and unresponsiveness of 
patients to therapy [34]. Side effects of dopamine 
therapy and the limited brain capacity for self-repair 
encouraged scientists to perform trials on cell-based 
therapy including adrenal medullary autograft [26].
Using autografts, as autologous cellular sources 
of dopamine, has been chosen for the treatment of 
PD because of the ease of tissue collection without 
the ethical and immunological problems inherent 
in allogeneic and xenogeneic tissue. The autografts 
therapy for PD included autologous cells from sym-
pathetic ganglion neurons, carotid body, and adrenal 
medulla, although overall results to date have been 
disappointing [45].
The first clinical trial of using adrenal medullary 
autograft to caudate nucleus showed a dramatic 
response of PD symptoms in 2 patients [30] then the 
results showed less favourable outcomes in terms of 
decreased positive effects of pharmacological treat-
ment [19].
Adrenal medulla consists of chromaffin cells, the 
majority of cells, which convert the amino acid tyros-
ine into adrenaline, noradrenaline, and dopamine; 
sustentacular cells, which are spindle or branched 
cells at the periphery of nests of chromaffin cells and 
are homologous in nature with Schwann cells; and 
ganglion cells [39].
S100 proteins are normally present in cells derived 
from the neural crest (Schwann cells and melano-
cytes), chondrocytes, adipocytes, myoepithelial cells, 
macrophages, Langerhans cells [14, 46], and dendritic 
cells [41]. It was found that S100 protein is detected in 
the normal adrenal medullary tissue. S100 expression 
is increased in the cytoplasm of degenerative adrenal 
chromaffin cells as a result of their penetration by 
the cytoplasmic processes of sustentacular cells [10].
It was noticed that inhibition of ubiquitin-proteas-
ome degradation system (UPS) and tyrosine hydroxy-
lase (TH) play the principal role in the pathogenesis of 
PD. The UPS is responsible for degradation of many 
cellular proteins [15].
Tyrosine hydroxylase is present in all dopaminergic 
cells and catalyses the formation of L-DOPA resulting 
in dopamine synthesis [1]. TH is found in diverse tis-
sues comprising the central and sympathetic nervous 
system and adrenal medulla [20]. The activity of TH is 
often as low as 25% of healthy age-matched controls. 
However, in Parkinsonism, this activity could fall to 
10% [20].
Post-mortem studies showed poor survival of 
grafted tissue [25, 28] after an autologous adrenal 
medullary transplantation, with few surviving chro-
maffin positive cells and complete absence of cells 
stained with TH at the graft site [27]. These data 
give the possibility of pathological changes affecting 
the dopamine secreting cells of the central nervous 
system, as well as those of the peripheral nervous 
system and the adrenal medulla.
This study aimed to investigate the histological 
and immunohistochemical changes in the adrenal 
medulla of AS and AS/AGU rats in a trial to explain 
the non-effectiveness of adrenal medullary autografts 
as an option for the treatment of PD.
MAterIAlS And MethodS
Animals
A total of 12 male Albino Swiss (AS) rats and 
12 male AS/AGU rats were divided into four groups, 
each of 6 animals: AS W1 — AS rats aged 1 week; AS 
adult — AS adult rats; AS/AGU W1 — AS/AGU rats 
aged 1 week; and AS/AGU adult — AS/AGU adult rats.
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The rats were obtained from the Experimental Ani-
mal Centre in College of Medicine, King Saud University, 
Saudi Arabia. The rats were maintained with water and 
food, ad libitum, at constant humidity and temperature. 
Under anaesthesia, the rats were euthanised by cardiac 
perfusion with mammalian Ringer’s solution and 4% 
paraformaldehyde in 0.1 M phosphate buffer. The ani-
mals were dissected and adrenal glands were excised 
and stored in 4% paraformaldehyde in phosphate buffer 
over-night, then embedded in paraffin wax at 57°C. Se-
rial sections were cut at 4 µm and stained for histological 
and immunohistochemical studies. All the experimental 
procedures were conducted according to the Guidelines 
for the Care and Use of Laboratory Animals of the Col-
lege of Medicine Research Centre (CMRC) at King Saud 
University and conform to the Guide for the Care and 
Use of Laboratory Animals published by the National 
Institutes of Health (NIH).
Histological studies
Haematoxylin and eosin (H&E) [17] and periodic 
acid Schiff (PAS) [13] were used for histological evalu-
ation and detection of adrenomedullary inclusion 
bodies (Lewy’s bodies), respectively.
Immunohistochemistry
Immunostaining of the paraffin sections of the 
adrenal glands for detection of S100 protein, ubiq-
uitin and TH were performed using streptavidin- 
-biotinylated horseradish peroxidase (S-ABC) method 
(Novalink Max Polymer detection system, Novocastra, 
product NO. RE7280-K). The procedure involved the 
following steps: endogenous peroxidase activity was 
inhibited by 3% H2O2 in distilled water for 5 min, 
and then the sections were washed in Tris buffered 
saline (TRS) (Sigma, T 5030-100 TAB, pH 7.6) twice; 
5 min for each. Non-specific binding to antibodies 
was blocked by incubation with protein block for 
5 min (Novocastra). Sections were incubated with 
anti-S100 antibody (rabbit polyclonal, dilution 1:500) 
(Cat# abcam-ab868), anti-ubiquitin mouse mono-
clonal (ub-A5: sc166553) at dilution of 1:100, and 
anti-TH antibody (rabbit polyclonal antibody, dilu-
tion 1:1000; GenWay Trust-GWB; 760869). All slides 
were incubated with the primary antibodies for 1 h 
at room temperature. Sections were washed in Tris 
buffer for 3 times; each for 3 min, and then incubated 
with biotinylated anti-rabbit IgG (Novocastra) for 
30 min. This was followed by washing in Tris buffer 
for 3 times, each for 3 min, and then incubated with 
Novolink polymer (Novocastra) for 30 min. Then sec-
tions were washed in Tris buffer for 3 times; each for 
3 min. Peroxidase was detected with working solution 
of diaminobenzidine (DAB) substrate (Novocastra) 
for 10 min. Finally, sections were washed in distilled 
water for 10 min. The sections were counterstained 
with Mayer’s haematoxylin and then mounted in DPX 
(Dysterene, Plasticizer, Xylene). For negative control 
sections, the same procedure was followed but with 
omission of incubation with the primary antibodies. 
Positive controls for S-100, ubiquitin, and TH are 
astrocytes, HqC2 cells, and brain, respectively.
Image analysis
High-resolution whole-slide digital scans of S100, 
TH- and ubiquitin-immunostained sections were cre-
ated with a ScanScope scanner (Aperio Technolo-
gies, Inc.). The digital slide images were then viewed 
and analysed using the viewing and image analysis 
tools of Aperio’s ImageScope software (Aperio Tech-
nologies, Inc.). Five areas, each with the fixed size 
of 0.066 mm2, were randomly selected per section. 
To quantify the immunopositive reaction, the colour 
deconvolution (colour separation) algorithm (Aperio 
Technologies, Inc.) was set up (by colour calibration) 
to detect and quantify only the brown colour of DAB 
positive staining. The algorithm was then run on the 
selected area to measure the percentage of immu-
nopositive reaction relative to the total analysis area. 
Cells positive for Lewy’s bodies (as visualised in PAS-
stained sections), in 5 randomly selected high-power 
fields per section, were counted and their percentage, 
relative to the total number of cells in the field, was 
calculated using the Manual Tag feature of Image-Pro 
Plus, Version 6 (Media Cybernetics, Inc.). All image 
analysis output results were finally exported to Excel 
sheets and subjected to statistical analysis.
Statistical analysis
Data collected were subjected to statistical analy-
sis using IBM SPSS Statistics, Version 22. The normal-
ity and homogeneity of variances of the data were 
first checked by Shapiro-Wilk test and Levene’s test, 
respectively. Analysis of variance (ANOVA) was then 
used for an overall comparison between the stud-
ied groups followed by Scheffe’s test for post hoc 
pairwise comparisons. Differences were considered 
significant when p was equal to or less than 0.05.
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reSUltS
Haematoxylin and eosin-stained sections of the 
adrenal medulla from both 1-week-old and adult AS 
rats showed normal features of chromaffin cells which 
appeared as polyhedral large cells arranged in cords 
and clusters. These cords and clusters are separated 
by blood vessels (Fig. 1A, C). H&E-stained sections 
of the adrenal medulla from 1-week-old AS/AGU 
rats showed vascular congestion and multiple foci of 
inflammatory cellular infiltration (Fig. 1B). Sections 
from adult AS/AGU rats showed similar histopatho-
logical changes in addition to large foci of necrotic 
chromaffin cells (Fig. 1D).
Periodic acid Schiff-stained sections of adrenal 
medulla from both 1-week-old and adult AS rats 
showed few chromaffin cells with Lewy’s bodies, 
which appeared as PAS-positive spherical inclusion 
bodies (Fig. 2A, C). However, 1-week-old AS/AGU rats 
and adult AS/AGU rats showed significantly higher 
percentages of chromaffin cells with Lewy’s bodies 
compared to 1-week-old AS rats and adult AS rats, 
respectively (Figs. 2B, D; 6A).
S100-immunostaining of adrenal medulla from 
AS/AGU rats of both ages showed significantly lower 
area per cent of immunopositively stained susten-
tacular cells (Fig. 3B, D) as compared to AS rats of 
both ages (Figs. 3A, C; 6B). S-100 immunoreaction 
was detected in both cytoplasm and nucleus of sus-
tentacular cells.
Ubiquitin-immunostaining of adrenal medulla 
from AS/AGU rats of both ages showed significantly 
lower area per cent of immunopositively stained chro-
maffin cells (Fig. 4B, D) compared to AS rats of both 
ages (Figs. 4A, C; 6C). Ubiquitin immunoreaction was 
observed in both cytoplasm and nucleus of chromaf-
fin cells. Lewy’s bodies were seen as inclusion bodies 
with immunopositive staining of their periphery. The 
Lewy’s bodies were more numerous in AS/AGU rats 
of both ages (Fig. 4B, D) compared to AS rats of both 
ages (Fig. 4A, C).
Tyrosin hydroxylase-immunostaining of the ad-
renal medulla from AS/AGU rats of both ages showed 
significantly lower area per cent of immunopositively 
stained chromaffin cells (Fig. 5B, D) compared to AS 
rats of both ages (Figs. 5A, C; 6D). TH immunoreaction 
was demonstrated in the cytoplasm of chromaffin 
cells. In adults groups, the TH-immunostaining was 
of mild intensity in AS rats (Fig. 5C) and almost com-
pletely negative in AS/AGU rats (Fig. 5D).
dIScUSSIon
The adrenal medulla and the sympathetic nervous 
system constitute an anatomical and physiological 
unit [47]. The sympathetic nervous system has already 
Figure 1. Photomicrographs of haematoxylin and eosin-stained sections of adrenal medulla. Scale bars = 50 µm. A. One-week-old AS rats 
showing normal cells; B. One-week-old AS/AGU rats showing multiple foci of inflammatory cellular infiltration (arrows); C. Adult AS rats 
showing normal cells; D. Adult AS/AGU rats showing large foci of necrotic chromaffin cells (asterisks).
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been recognised as a pathological site in PD [44]. PD 
is frequently accompanied by a variety of autonomic 
symptoms. The adrenal medulla is a major component 
of the autonomic nervous system, thus the adrenal 
medulla appears to be a target of the peripheral 
manifestations of PD [42].
The histological study of adrenal medulla of AS/ 
/AGU rats of the current study showed vascular con-
Figure 3. Photomicrographs of S-100 immunostained sections of adrenal medulla. Scale bars = 50 µm; A. One-week-old AS rats showing 
strong S100 expression in sustentacular cells (arrow); B. One-week-old AS/AGU rats showing weak positively immunostained cells (arrow); 
C. Adult AS rats showing increase in the number and volume of S100 positively immunostained cells (arrow); D. Adult AS/AGU rats showing 
marked decrease in number and size of S100 positively immunostained cells (arrow).
Figure 2. Photomicrographs of periodic acid Schiff (PAS)-stained sections of adrenal medulla. Scale bars = 20 µm; A. One-week-old AS rats 
showing few chromaffin cells with PAS-positive medullary bodies (arrow); B. One-week-old AS/AGU rats showing few chromaffin cells with 
PAS-positive medullary bodies (arrow); C. Adult AS rats showing few chromaffin cells with PAS-positive medullary bodies (arrow); D. Adult 
AS/AGU rats showing numerous chromaffin cells with PAS-positive medullary bodies (arrow).
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gestion, inflammatory cellular infiltration in 1-week-
-old rats, in addition to foci of necrotic chromaffin 
cells in adult rats.
The results of the present study were in agreement 
with others who observed that the progressive degenera-
tive changes affected the neuronal cells of adrenal me-
Figure 4. Photomicrographs of ubiquitin immunostained sections of adrenal medulla. Scale bars = 50 µm; A. One-week-old AS rats showing 
moderate immunostaining; B. One-week-old AS/AGU rats showing moderate immunostaining in few cells and few Lewy’s bodies (arrow); 
C. Adult AS rats showing strong immunostaining of numerous cells. Few cells show Lewy’s bodies (arrow); D. Adult AS/AGU rats showing 
many cells with Lewy’s bodies (arrows).
Figure 5. Photomicrographs of tyrosine hydroxylase immunostained sections of adrenal medulla. Scale bars = 50 µm; A. One-week-old AS rats 
showing strong immunostaining of medullary cells; B. One-week-old AS/AGU rats showing moderate immunostaining of medullary cells; C. Adult  
AS rats showing mild immunostaining of medullary cells; D. Adult AS/AGU rats showing negative immunoreaction of almost all medullary cells.
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dulla, similar to other neuronal cells, including the central 
nervous system (CNS), in PD rat models [21]. The necrotic 
and apoptotic process is a characteristic pathological 
picture of neuronal cells in PD [18]. The current study 
showed that the histological changes in terms of necrosis 
were more apparent in the AS/AGU adult rats compared 
to 1-week-old rats. This finding was in agreement with 
other researchers who revealed increased progression of 
CNS degeneration with age as a characteristic feature of 
PD [3]. The aetiology of PD is still unknown but the pres-
ence of inflammatory cell infiltrate suggests that it plays 
an important role in the degeneration of the neuronal 
cells [6, 7]. Tumour necrosis factor (TNF)-alpha is the first 
pro-inflammatory cytokine induced by the inflammatory 
cell infiltrate, which induces cell death through the acti-
vation of TNF-receptors (TNF-R) and consequently stimu-
lates and activates apoptotic signal and neuronal death 
[4, 8, 29, 32]. Other pro-inflammatory cytokines which 
are secreted by inflammatory cell infiltrate, such as inter-
feron gamma and interleukins, are also elevated in brain, 
blood, and CSF of PD patients [5, 32, 33, 43]. According 
to these data, these circulating cytokines increasing in the 
blood can affect the cells of adrenal medulla. The histo-
logical changes in AS/AGU rats, in the current study, could 
be also attributed to the increased free radicals genera-
tion and impaired mechanisms of their scavenging. These 
include enzyme superoxide dismutase, which converts 
superoxide ions to hydrogen peroxide, and glutathione 
peroxidase, which enhances the reaction of hydrogen 
peroxide with reduced glutathione to produce water 
[18]. These mechanisms may play an important role in 
the pathogenesis of PD.
Figure 6. Graphical representation of image analysis data; A. Mean percentage of Lewy’s bodies positive cells; B. Mean area per cent of 
S100 immunopositivity; C. Mean area per cent of ubiquitin immunopositivity; D. Mean area per cent of tyrosine hydroxylase immunopositivity; 
*Significant difference (p ≤ 0.05) between AS/AGU and AS groups.
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The PAS-stained sections showed marked and more 
numerous PAS positive stained medullary inclusion 
bodies in the chromaffin cells of the adrenal medulla 
of AS/AGU rats. It has been shown that the number of 
adrenomedullary inclusions per unit area of the adrenal 
medulla in patients complaining of PD and other Lewy 
body disorders (LBD) was higher compared to other 
neurological diseases and apparently healthy subjects 
without any autonomic dysfunctions, and correlated 
with the duration of LBD. It was reported that the 
cells which contain adrenomedullary inclusions are 
all norepinephrine-secreting chromaffin cells [44]. The 
presence of adrenomedullary inclusions indicates cel-
lular degeneration which may be ascribed to a defect of 
norepinephrine reuptake and metabolism [47] or due 
to a long-term acceleration of the secretion of adre-
nomedullary norepinephrine in PD resulting in high 
circulating levels of norepinephrine [44]. The results of 
the current study revealed an increase in the number 
of Lewy’s bodies in AS/AGU rats compared to AS rats 
that proportionally increased with age. Young [47] 
reported that marked and numerous adrenomedullary 
inclusions are observed in the adrenal glands of people 
without PD but the accelerated, marked and numerous 
inclusions are indicating degenerative norepinephrine-
producing cells which are a characteristic feature of PD. 
The S100 immunopositive staining was weakly 
expressed in sustentacular cells of adrenal medulla 
of AS/AGU rats compared to the AS rats in differ-
ent age-groups. The increased expression of S100 
plays a role in the pathogenesis of degeneration of 
dopaminergic neurons at acute phase after 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment 
[24]. Also, S100-immunopositive cells were found in 
the striatum and substantia nigra of control mice and 
increased from first to the third day and then decreased 
afterward in MPTP-induced PD [35]. Our results failed 
to find increased expression of S100 immunopositive 
cells, which may be due to the fact that we started to 
investigate the slides by the end of week one.
The current results showed decreased expression 
of ubiquitin in chromaffin cells of adrenal medulla of 
AS/AGU rats of both ages compared to the AS rats of 
both ages. Ubiquitin is an intracellular protein degra-
dation system that is responsible for the majority of 
protein turnover within the cell [23]. The decreased 
ubiquitin could be a cause or result of PD in AS/AGU 
groups of our study.
The presence of ubiquitin positive peripheral ex-
pression of the cytoplasmic inclusions indicated the 
presence of Lewy’s bodies, which consist of a hetero-
geneous mixture of proteins and lipids. Lipids form the 
core of the inclusions while the peripheral filamentous 
elements include proteins such as ubiquitin, neurofila-
ment and various proteasomal elements [31]. It was 
postulated that aberrant proteins accumulate and tend 
to aggregate when the UPS is impaired [40].
The aggregation of inclusion (Lewy’s) bodies indi-
cates increased accumulation of toxic soluble proteins 
(a-synuclein) in PD [11], which is considered as 
a protective measure for the neuronal cells. However, 
excessive build-up of aggregates can also be toxic to 
cellular functions, resulting in chromaffin cell death.
Our results also showed a weak expression of TH 
immunopositive staining in adrenal medulla of AS/ 
/AGU groups compared to the AS controls. Also, it 
was noted that the expression of TH was decreased in 
AS/AGU adult group compared to 1-week-old group.
TH is present in all dopaminergic cells, including 
the adrenal medulla, and catalyses the formation of 
L-DOPA. It was reported that a deficiency in TH is 
a hallmark of PD [1]. It has been noted also that the ac- 
tivities of TH was significantly decreased in the adrenal 
medulla in patients with PD [38]. The decreased TH 
activities in AS/AGU adult group compared to AS/AGU 
1 week group could be attributed to the progression 
of PD resulting in decreases in the activities of TH of 
the chromaffin cells [22].
Clinical implication
The histological and immunohistological changes 
in the adrenal medulla could explain the failure of 
adrenal autograft therapy in PD.
Limitations of the study
Our study has some limitations such as neglect-
ing the detection of a-synuclein immunohistochem-
istry to verify the presence of Lewy’s bodies, but 
we believe that ubiquitin immunohistochemistry 
has the same reliability in this verification. Another 
limitation of the study is the relatively low number 
of evaluated animals but that was because of the 
rarity of the AS/AGU strain. We recommend further 
studies to be done using different PD animal models 
to verify our results.
conclUSIonS
As far as we know, this is the first study that 
extensively investigated the adrenal medulla in PD 
on histological and immunohistochemical basis. The 
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histological and immunohistochemical findings of our 
study showed that the adrenal medulla is a target for 
the pathological changes of PD, which may explain 
the failure of adrenal medulla autograft therapy in 
PD patients.
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